No Data
Weight-Loss Drugs Are Everywhere. How the GLP-1 Copycats Took Over. -- Barron's
Novo Nordisk's Options: A Look at What the Big Money Is Thinking
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
What End of Eli Lilly's Weight-loss Drug Shortage Means for the Competition
Eli Lilly's Mounjaro, Zepbound Removed From FDA's Shortage List
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
loading...
loading...
股勇者 : any opening CSP trades?